ClinicalTrials.Veeva

Menu

Comprehensive Frailty Assessment

The Ohio State University logo

The Ohio State University

Status

Completed

Conditions

Hematologic Neoplasms
Myeloma, Multiple
Paraproteinemias

Study type

Observational

Funder types

Other

Identifiers

NCT02033928
OSU-13135

Details and patient eligibility

About

The purpose of this research study is to describe a patients' fitness before and after treatment (whether that treatment be chemotherapy or a transplant). Fitness is a way of measuring a patient's current quality of health. With surveys, questionnaires and blood tests, we hope to create a tool that will give a good picture of patients' ability to tolerate treatment. In the future, we hope to devise the best treatment for a patient based on their "fitness".

Enrollment

111 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with a plasma cell dyscrasia AND/OR any patient receiving a stem cell transplant for a hematologic malignancy at The Ohio State University
  • at least 18 years of age

Exclusion criteria

  • Any medical or psychiatric condition that would make it difficult for the patient to comply with study procedures.

Trial design

111 participants in 2 patient groups

Arm I: Transplant patients
Arm II: Plasma cell dyscrasia patients

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems